4//SEC Filing
NPS PHARMACEUTICALS INC 4
Accession 0000890465-13-000013
CIK 0000890465operating
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 8:24 PM ET
Size
10.5 KB
Accession
0000890465-13-000013
Insider Transaction Report
Form 4
GRONINGER JAMES G
Director
Transactions
- Exercise/Conversion
Stock Options
2013-08-20−10,000→ 26,000 totalExercise: $4.24Exp: 2019-09-30→ Common Stock (10,000 underlying) - Gift
Common Stock
2013-08-20−3,000→ 750 total - Exercise/Conversion
Common Stock
2013-08-20$4.24/sh+10,000$42,400→ 20,650 total - Sale
Common Stock
2013-08-20$23.21/sh−16,900$392,222→ 3,750 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2013
- [F2]Stock options granted under NPS Pharmaceuticals Inc.'s (the "Issuer") amended and restated 2005 Omnibus Incentive Plan (the "Plan"). The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the date of grant and 6.25% every three months thereafter.
- [F3]The price shown above represents the weighted average price of the shares sold. The range of sales prices was 23.20 and 23.24. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC Staff, upon request, information regarding the number of shares sold at each price within the range of prices actually paid.
Documents
Issuer
NPS PHARMACEUTICALS INC
CIK 0000890465
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000890465
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 8:24 PM ET
- Size
- 10.5 KB